Daoqi You

3.8k citations
22 papers · 1.3k indexed · h-index 11
Topics
Cancer Genomics and Diagnostics (11 papers)Cellular transport and secretion (3 papers)Advanced Breast Cancer Therapies (2 papers)

In The Last Decade

Daoqi You

19 papers receiving 1.3k citations

Peers

Daoqi You
Comparison fields: 5 of 65
  • Molecular Biology 616
  • Oncology 381
  • Cancer Research 370
  • Pulmonary and Respiratory Medicine 362
  • Cell Biology 330
Replace Weon‐Kyoo You with:
Weon‐Kyoo You South Korea
Laurent Sansregret Canada
Randolph S. Watnick United States
Guido W.M. Swart Netherlands
Juha Rantala Finland
Thomas Kitzing Germany
Ian Tomlinson United Kingdom
Swapna S. Vemula United States
Ana Rita Nobre Portugal
Akash Nanda United States
Daoqi You relative to Weon‐Kyoo You South Korea Weon‐Kyoo You's profile →
Citations per field
00.5×1.7×
Weon‐Kyoo You · 1×
Citations per year

Countries citing papers authored by Daoqi You

Since Specialization
Citations

This map shows the geographic impact of Daoqi You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoqi You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoqi You more than expected).

Fields of papers citing papers by Daoqi You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoqi You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoqi You. The network helps show where Daoqi You may publish in the future.

Co-authorship network of co-authors of Daoqi You

This figure shows the co-authorship network connecting the top 25 collaborators of Daoqi You. A scholar is included among the top collaborators of Daoqi You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoqi You. Daoqi You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 8
6 4
7 0
8 2
9 111
10 6
11 30
12 51
13 52
14 347
15 37
16 31
17 112
18 124
19 106
20 298

About Daoqi You

Daoqi You is a scholar working on Cancer Research, Hematology and Cell Biology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Cellular transport and secretion (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (370 citations), Immunology and Allergy (128 citations) and Cell Biology (330 citations). Daoqi You has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Aliaksandra Samoila, Thomas J. Melia, Sarat Chandarlapaty, Patricia Sung, José Baselga, Mary Ellen Moynahan, Parul Patel, Michael K. Rosen, James E. Rothman and Michael Gnant. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026